1. Abel, J. G., Sellers, E.M., Naranjo, C. A., Shaw, J., Kadar, D. and Romach, M.K. (1979). Inter- and intrasubject variation in diazepam free fraction. Clin. Pharmacol. Ther., 26, 247
2. Alvan, G. (1978). Individual differences in the disposition of drugs metabolised in the body. Clin. Pharmacokin., 3, 155
3. Amrein, R., Cano, J.P. and Hügin, W. (1976). Pharmakokinetische und pharmakodynamische Befunde nach einmaliger intravenöser, intramuskulärer und oraler Applikation von ’Rohypnol’. In Hügin, W., Hossli, G. and Gemperle, M. (eds.). Bisherige Erfahrungen mit ’Rohypnol’ (Flunitrazepam) in der Anästhesiologie und Intensivtherapie, pp. 39–56. (Basel: Editiones Roche)
4. Amrein, R., Cano, J.P., Hartmann, D., Ziegler, W.H. and Dubuis, R. (1979). Clinical and psychometric effects of flunitrazepam observed during the day in relation to pharmacokinetic data. In Priest, R.G., Pletscher, A. and Ward, J. (eds.). Sleep Research, pp. 83–98. (Lancaster: MTP Press Limited)
5. Andreasen, P.B., Hendel, J., Greisen, G. and Hvidberg, E. F. (1976). Pharmacokinetics of diazepam in disordered liver function. Eur. J. Clin. Pharmacol, 10, 115